P1.14-08 Activity of Poziotinib and Other 2nd-Gen Quinazoline EGFR TKIs in Atypical Exon18 and Acquired Osimertinib Resistance Mutants

Autor: Robichaux, J., Le, X., Elamin, Y., Nilsson, M., Hu, L., He, J., Zhang, F., Poteete, A., Sun, H., Rinsurongkawong, W., Cross, J., Heymach, J.
Zdroj: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S555-S555
Databáze: ScienceDirect